Navigation Links
Osseon Therapeutics Demonstrates to the European Medical Community How to 'Think Outside The Balloon' When Treating Vertebral Compression Fractures
Date:4/29/2010

LIVERPOOL, England, April 29 /PRNewswire/ -- At this week's BritSpine 2010 conference, Osseon Therapeutics is demonstrating to European surgeons and interventional radiologists how they can "think outside the balloon" when it comes to treating vertebral compression fractures brought on by osteoporosis, benign or malignant lesions and trauma.

The company's groundbreaking Osseoplasty 1.0 percutaneous vertebral augmentation system provides a safe, fast alternative for vertebral augmentation with cavity creation, and does so without  obstacles and device related complications and issues associated with other vertebral augmentation products.

"A recent study published in the January 2010 edition of the American Journal of Neuroradiology entitled Balloon-Related Complications and Technical Failures in Kyphoplasty for Vertebral Fractu
'/>"/>

SOURCE Osseon Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Osseon Launches in Europe
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "MEMS Gyroscopes Analog ... Analysis" report to their offering. ... gyroscopes for tactical grade applications made a lot ... term of reliability. They are now accepted in ...
(Date:12/15/2014)... 15, 2014 BerGenBio AS, a ... drug resistant cancers, today announces that it has raised ... from new and existing investors. BerGenBio will ... development of its pipeline of innovative cancer therapeutics, in ... drug candidate, BGB324, a first-in-class selective Axl kinase inhibitor, ...
(Date:12/15/2014)... -- Colorado and Washington State are not ... Oregon , Alaska , ... the November 2014 elections. Photo - ... The benefits of legalizing cannabis are manifold. There ... increased tax revenue for state and local governments, in addition ...
Breaking Medicine Technology:MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2BerGenBio Completes NOK90 Million Fundraising 2CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2
... Aug. 13 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: ... marketing and distribution partner in Japan, has,submitted a ... Japanese Ministry of Health, Labour and Welfare. ... to bring the first drug,treatment option to MPS ...
... Texas, Aug. 13 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... an oral presentation at the American Chemical Society ... August 21, 2007,at 2:50 p.m. Eastern Time. The ... serotonin levels by enzyme inhibitors for the,potential treatment ...
Cached Medicine Technology:BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health 2BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health 3BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health 4Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate 2Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate 3
(Date:12/17/2014)... Expectant parents should leave prenatal picture-taking to medical professionals, ... of ultrasound imaging and heartbeat monitors to get "keepsake" ... warns. "Although there is a lack of ... heartbeat monitors, prudent use of these devices by trained ... biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... improve overall health, but a growing body of evidence shows ... review finds. In fact, the benefits were similar to ... researcher Paula Chu, a doctoral candidate at Harvard University,s Health ... trials, found that people randomly assigned to take yoga classes ...
(Date:12/15/2014)... December 15, 2014 Veretekk.com, Inc. announced ... Ocean Avenue. JM Ocean Avenue has secured exclusive ... online automated marketing system. JM Ocean Avenue is ... merger of Ocean Avenue and JM International, with partial ... Billion per year company. , “After nearly 2 decades ...
(Date:12/15/2014)... 2014 OutMarket , a provider ... Social Media Cheat Sheets ,” a guide that exposes ... results on the top ten social media networks. ... drive awareness, engagement, and customer service. It can also ... an impact on new networks and weather constantly changing ...
(Date:12/15/2014)... December 15, 2014 The increase in prevalence ... of the main factors which is contributing to the growth ... the diagnosis and treatment of hearing loss and balance disorders ... three parts - microphone, speaker and amplifier. The global market ... of 6.01% during the period from 2014 to 2019. Some ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
... Minn. Mayo Clinic has received investigational ... the Food and Drug Administration ( http://www.fda.gov/ ... mobilize the body,s defense mechanisms to destroy ... first aimed at preventing cancer recurrence. The ...
... News) -- Although not life-threatening, sprains and strains account ... in U.S. emergency departments, according to a new study. ... emergency hotline or scheduled doctor appointments, would spare valuable ... Hospital in Boston, said in the report, recently published ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... this week expressed growing concerns over a rise in rates ... New data released Tuesday at the National HIV Prevention Conference ... that 19 percent of gay and bisexual men, 9 percent ...
... Reporter , TUESDAY, Aug. 16 (HealthDay News) -- Almost half ... and the risk of bladder cancer has increased significantly for ... Smokers now face a four times higher risk of ... years ago, that risk was about three times that of ...
... TUESDAY, Aug. 16 (HealthDay News) -- ,Scientists who identified ... a need for gender-specific drug therapies for some diseases. ... blood serum from more than 3,000 people and found ... in lipids and amino acids. The results prove ...
... , TUESDAY, Aug. 16 (HealthDay News) -- Black women ... are less likely to breast-feed, putting them at greater risk ... a new study. The study, published in the ... found the risk for hormone receptor-negative breast cancer was 50 ...
Cached Medicine News:Health News:Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines 2Health News:Sprained Ankles Straining ER Resources, Study Finds 2Health News:Experts Concerned About Rising HIV Rates Among Poor, Minorities 2Health News:Bladder Cancer Risk Even Higher for Smokers Than Thought 2Health News:Bladder Cancer Risk Even Higher for Smokers Than Thought 3Health News:Blacks at Higher Risk for Resistant Breast Cancer: Study 2
Inquire...
Inquire...
Nature's Remarkable Skin Protector -- Karaya 5 is a natural skin barrier that is particularly well suited for skin problems or for sensitive skin where reactions may have occurred to other types of s...
Superior Skin Care...FlexWear skin barrier provides skin protection for an extended wear time....
Medicine Products: